Krystal Biotech, Inc.
(NASDAQ: KRYS)

Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

272.910 -

-4.450 (-1.60%)
Range 272.150 - 279.620   (2.74%)
Open 278.190
Previous Close 277.360
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 260,023
Value 65,333,646
Remark -
Delayed prices. Updated at 29 Jan 2026 09:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis